Eisai invests $15m in C₂N Diagnostics to advance Alzheimer’s disease diagnostics

In a significant move for the field of brain health diagnostics, C₂N Diagnostics, LLC, a pioneer in developing advanced diagnostic solutions for Alzheimer's disease, has ... Read More